A randomised controlled trial comparing spontaneous ureteric stone passage rates with tamsulosin versus placebo in the management of acute renal colic

Completed

• Conditions: rological and Genital Diseases: Acute renal colic; Urological and Genital Diseases; Acute renal colic

• Registration Number: ISRCTN24675122
• Lead Sponsor: Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 206

Inclusion Criteria

The total sample size required to produce statistically significant results is 206 patients (103 to receive placebo). All patients with renal colic with a visible calculus on X-ray which has been confirmed to be present within the ureter on intravenous urogram (IVU) will be asked to participate.

Exclusion Criteria

Patients will be excluded if pregnant, symptoms present for >14 days, evidence of infection or if they are already receiving treatment with tamsulosin or other calcium channel blocker.

Study & Design

• Study Type: Interventional
• Study Design: Not specified